ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1229	46	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1016	Avoro?	CCS648	-	May 7
1015	Like many here have said, this is acting very much like IMMU and has given many	galt	5	May 7
1014	de-ja vu...........reminds me of the time idahoranch talked of adding under 2$ I	urslor	3	May 7
1013	This is going to be the confirmatory trail for NSCLC. It recently updated to rec	mannamal	3	May 7
1012	clinicaltrials.gov	mannamal	3	May 7
1011	Press releases are typically drafted by Comms or Marketing departments and roll	TinfoilHat	3	May 6
1010	My only quibble with your observation of the perhaps intentional obfuscation via	jargonweary	-	May 6
1009	Having held IMMU for many years and endured similar disappointments I would just	jargonweary	7	May 6
1008	The press release reads to me like a CYA from management/PSS to the new investor	Maturin	2	May 6
1007	I did not hold IMMU, but I’ve seen so many references - it has given me a little	CCS648	1	May 6
1006	"But if that’s your perception of the intent (obfuscation), why are you an	Fitzhughlaw	4	May 6
1005	Happily, I did not do corporate defense work, nor is that the focus of my positi	CCS648	-	May 6
1004	"[T]he 8-k response does not read to me like it was written by a lawyer.&qu	Fitzhughlaw	3	May 6
1003	Or possibly the people who led IBRX officials to believe that the application wo	CCS648	3	May 6
1002	I know you’re a lawyer, as was I (judge now), and thus pay close attention to wo	CCS648	-	May 6
1001	Picked up another 7k shares this morning so hopefully we get clarity soon...	erippetoe	-	May 6
1000	I am prepared to believe that the FDA encouraged them to file and, if true, that	jargonweary	4	May 6
999	So upon further review of the company's PR, I need to amend my prior absolut	Fitzhughlaw	4	May 6
998	"[S]ome institutions exit and others are clearly uninterested. Why? Perhaps	Fitzhughlaw	8	May 5
997	Sounds eerlily familiar, as in IMMU, except that IBRX already has one approved i	galt	1	May 5
996	This is dated, but informative just the same: fda.gov	mannamal	-	May 5
995	I am not adding more at this point because a) I already have too much and, b) I	jargonweary	1	May 5
994	Unfortunately, this could lead to another class action suit. Just saying, but ho	galt	3	May 5
993	Obviously the company was working their response all weekend long given they rec	Maturin	-	May 5
992	Managing the regulatory process is perhaps the most important responsibility for	jargonweary	3	May 5

Go to reply# or date (mm/dd/yy):